You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Baxter
AstraZeneca
Harvard Business School
Colorcon

Last Updated: May 15, 2021

DrugPatentWatch Database Preview

Magnesium chloride; sodium bicarbonate; sodium chloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for magnesium chloride; sodium bicarbonate; sodium chloride and what is the scope of patent protection?

Magnesium chloride; sodium bicarbonate; sodium chloride is the generic ingredient in two branded drugs marketed by Dialysis Sups and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Magnesium chloride; sodium bicarbonate; sodium chloride has four patent family members in four countries.

There are one hundred and forty-six drug master file entries for magnesium chloride; sodium bicarbonate; sodium chloride.

Summary for magnesium chloride; sodium bicarbonate; sodium chloride
International Patents:4
US Patents:1
Tradenames:2
Applicants:1
NDAs:1
Drug Master File Entries: 146
Clinical Trials: 215
DailyMed Link:magnesium chloride; sodium bicarbonate; sodium chloride at DailyMed
Recent Clinical Trials for magnesium chloride; sodium bicarbonate; sodium chloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Tongji HospitalPhase 4
University of PittsburghN/A
Guy's and St Thomas' NHS Foundation TrustN/A

See all magnesium chloride; sodium bicarbonate; sodium chloride clinical trials

US Patents and Regulatory Information for magnesium chloride; sodium bicarbonate; sodium chloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dialysis Sups NORMOCARB HF 35 magnesium chloride; sodium bicarbonate; sodium chloride SOLUTION;INJECTION 021910-002 Jul 26, 2006 RX Yes Yes   Get Started for $10   Get Started for $10   Get Started for $10
Dialysis Sups NORMOCARB HF 25 magnesium chloride; sodium bicarbonate; sodium chloride SOLUTION;INJECTION 021910-001 Jul 26, 2006 RX Yes Yes   Get Started for $10   Get Started for $10 Y   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for magnesium chloride; sodium bicarbonate; sodium chloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dialysis Sups NORMOCARB HF 25 magnesium chloride; sodium bicarbonate; sodium chloride SOLUTION;INJECTION 021910-001 Jul 26, 2006   Get Started for $10   Get Started for $10
Dialysis Sups NORMOCARB HF 35 magnesium chloride; sodium bicarbonate; sodium chloride SOLUTION;INJECTION 021910-002 Jul 26, 2006   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for magnesium chloride; sodium bicarbonate; sodium chloride

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1499331 C300615 Netherlands   Get Started for $10 PRODUCT NAME: NATRIUMSULFAAT, MAGNESIUMSULFAAT EN KALIUMSULFAAT; NAT. REGISTRATION NO/DATE: RVG 110863 20130417; FIRST REGISTRATION: BE 434323 20130220
1020461 300482 Netherlands   Get Started for $10 PRODUCT NAME: NAXOPREN EN ESOMEPRAZOL ALS MAGNESIUMZOUT; NATIONAL REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: GB PL 17091/0263 - 0001 20101105
0984957 122012000051 Germany   Get Started for $10 PRODUCT NAME: KOMBINATIONSPRODUKT UMFASSEND NAPROXEN UND ESOMEPRAZOL-MAGNESIUM-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 85145.00.00 20120202; FIRST REGISTRATION: GROSSBRITANNIEN PL 17901/0263 - 0001 20101105
0124495 SPC/GB01/006 United Kingdom   Get Started for $10 PRODUCT NAME: ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE; REGISTERED: SE 15945 20000310; SE 15946 20000310; UK PL 17901/0068-0069 20000727
1499331 SPC/GB13/034 United Kingdom   Get Started for $10 PRODUCT NAME: IZINOVA CONCENTRATE FOR ORAL SOLUTION. THE ACTIVE SUBSTANCE IS A MIXTURE OF 3 SALTS:SODIUM SULPHATE ANHYDROUS, MAGNESIUM SULPHATE HEPTAHYDRATE AND POTASSIUM SULPHATE.; REGISTERED: BE BE434323 20130220; UK PL34926/0016 20130313
0984957 122012000017 Germany   Get Started for $10 PRODUCT NAME: ASPIRIN UND ESOMEPRAZOL - MAGNESIUM-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 81047.00.00 20110930 FIRST REGISTRATION: PORTUGAL 5402359 5402367 5402375 20110812
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Mallinckrodt
Baxter
Merck
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.